Psychiatric co-morbidity & diabetes

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 311-320

  Sridhar, G R ^a  

^a Endocrine and Diabetes Centre   (India)

Author keywords

Antipsychotic drugs; Depression; Diabetes

Indexed keywords

ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; ENZYME INHIBITOR; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRIACYLGLYCEROL LIPASE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; ZIPRASIDONE;

BEHAVIOR THERAPY; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; COPING BEHAVIOR; DEPRESSION; DEVELOPING COUNTRY; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; EATING DISORDER; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENTAL DISEASE; MENTAL STRESS; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORTHOSTATIC HYPOTENSION; PANCREAS ISLET BETA CELL; PHYSICIAN; PSYCHOSOCIAL DISORDER; REVIEW; RISK FACTOR; SCREENING TEST; SIDE EFFECT; URINE RETENTION; WEIGHT GAIN;

ATTITUDE TO HEALTH; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; HUMANS; MENTAL DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 34249324095     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Mohan V. Sandeep S, Deepa R, Shah B, Varghere C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-30.
2. Sridhar GR, Rao PV, Ahuja MMS. Epidemiology of diabetes and its complications. In: Ahuja MMS, Tripathy BB, Moses SGP, Chandalia HB, Das AK, Rao PV, editors. RSSDI textbook of diabetes. Hyderabad: Reseach Society for the Study of Diabetes in India; 2002 p. 95-112.
3. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44: 1094-101.
4. Huizinga MM, Rothman RL. Addressing the diabetes pandemic: A comprehensive approach. Indian J Med Res 2006; 124: 481-4.
5. Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004; 66: 301-7.
6. Weiss MG, Isaac M, Parkar SR, Chowdhury AN, Raguram R. Global, national, and local approaches to mental health: examples from India. Trop Med Int Health 2001; 6: 4-23.
7. Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, et al. Prevalence and treatment of mental disorders, 1990-2003. N Engl J Med 2005; 352: 2515-23.
8. McVeigh KH, Mostashari F, Thorpe LE. Serious psychological distress among persons with diabetes - New York City, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 1089-92.
9. Khandelwal SK, Jhingan HP, Ramesh S, Gupta RK, Srivastava VK. India mental health country profile. Int Rev Psychiatry 2004; 16: 126-41.
10. Tiwari SC. Geriatric psychiatric morbidity in rural northern India: implications for the future. Int Psychogeriatr 2000; 12: 35-48.
11. Nandi DN, Banerjee G, Mukherjee SP, Ghosh A, Nandi PS, Nandi S. Psychiatric morbidity of a rural Indian community. Change over a 20-year interval. Br J Psychiatry 2000; 176: 351-6.
12. Dey AB, Soneja S, Nagarkar KM, Jhingan HP. Evaluation of the health and functional status of older Indians as a prelude to the development of a health programme. Natl Med J India 2001; 14: 135-8.
13. Patel V, Andrade C. Pharmacological treatment of severe psychiatric disorders in the developing world: lessons from India. CNS Drugs 2003; 17: 1071-80.
14. Jacob KS, Bhugra D, Lloyd KR, Mann AH. Common mental disorders, explanatory models and consultation behaviour among Indian women living in the UK. J R Soc Med 1998; 91: 66-71.
15. Ananth A, Kolli S, Gunatilake S, Brown S. Atypical antipsychotic drugs, diabetes and ethnicity. Expert Opin Drug Safety 2005; 4: 1111-24.
16. Begum A, Mahtab H, Khan AKA. Psychiatric morbidity in recently diagnosed diabetic subjects. J Diab Assoc Bangladesh 1991; 19: 16-21.
17. Desai MM, Rosenheck RA, Druss B, Perlin JB. Mental disorders and quality of diabetes care in the Veterans Health Administration. Am J Psychiatry 2002; 159: 1584-90.
18. Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 2005; 165: 2631-8.
19. Ramachandran A. Experiences of the WHO Collaborating Centre for Diabetes in India in managing tsunami victims with diabetes. Pract Diabetes Int 2005; 22: 98-9.
20. Sridhar GR, Madhu K. Psychosocial and cultural issues in diabetes mellitus. Curr Sci 2002; 83: 1556-64.
21. Sridhar GR, Madhu K, Veena S. Gender differences in well-being among persons with diabetes in India. Diabetes Res Clin Pract 2000; 50: 981.
22. Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Med 2005; 165: 2497-503.
23. Rahman A, Iqbal Z, Bunn J, Lovel H, Harrington R. Impact of maternal depression on infant nutritional status and illness: a cohort study. Arch Gen Psychiatry 2004; 61: 946-52.
24. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-7.
25. Marteau TM. Understanding and avoiding the adverse psychological effects of screening: a commentary. In: Williams R, Herman W, Kinmonth L, Wareham NJ, editors. The evidence base for diabetes care. West Sussex, John Wiley & Sons; 2002 p. 235-41.
26. Madhu K, Sridhar GR. Stress management in diabetes mellitus. Int J Diab Dev Countries 2005; 25: 7-11.
27. Patel V, Pereira J, Mann AH. Somatic and psychological models of common mental disorder in primary care in India. Psychol Med 1998; 28: 135-43.
28. Chadda RK. Psychiatry in non-psychiatric setting - a comparative study of physicians and surgeons. J Indian Med Assoc 2001; 99: 24, 26-7, 62.
29. Farooq S, Akhter J, Anwar E, Hussain I, Khan SA, Inam-ul Haq Jadoon. The attitude and perception of hospital doctors about the management of psychiatric disorders. J Coll Phycians Surg Pak 2005; 15: 552-5.
30. Miller G. A spoonful of medicine - and a steady diet of normality. Science 2006; 311: 464-5.
31. Sridhar GR, Madhu K. Stress in the cause and course of diabetes. Int J Diab Dev Countries 2001; 21: 112-20.
32. Bjorntorp P, Rosmond R. The metabolic syndrome - a neuroendocrine disorder? Br J Nutr 2000; 83 (Suppl 1): S49-57.
33. Katz JR, Mohammed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf) 1999; 50: 63-8.
34. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097-102.
35. Freedland KE. Depression is a risk factor for the development of type 2 diabetes. Diabetes Spectr 2004; 17: 150-2.
36. Mooy JM, de Vries H, Grootenhuis PA, Bouter LM, Heine RJ. Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn study. Diabetes Care 2000; 23: 197-201.
37. Haupt D, Newcomer J. Depression is associated with hyperglycemia and other metabolic abnormalities. Diabetes Spectr 2004; 17: 154-5.
38. Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006; 103: 1593-8.
39. Anderson RJ, Freedland KE, Clouse RE, Listman PJ. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001; 24: 1069-78.
40. Sridhar GR, Madbu K. Depression and psychosocial stress in diabetes mellitus. In: Kapur A, Joshi JK, editors. Novo nordisk diabetes update proc. Mumbai: Business Network Inc; 2002 p. 87-92.
41. Lustman PJ, Clouse RE. Practical considerations in the management of depression in diabetes. Diabetes Spectr 2004; 17: 160-6.
42. Kohen D. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry 2004; 47 (Suppl): S64-6.
43. Fadel J, Bubser M, Deutch A. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 2002; 22: 137-41.
44. Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, et al. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naïve first-episode schizophrenia patients. J Clin Psychiatry 2004; 65: 1335-42.
45. Toalson P, Ahmed S, Hardy T, Kabinoff G. The metabolic syndrome in patients with severe mental illness. Prim Care Companion J Clin Psychiatry 2004; 6: 152-8.
46. Beyer J, Kuchibhatla M, Gersing K, Krishnan KR. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005; 30: 40-104.
47. Frankernburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illness, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 2004; 65: 1660-5.
48. Sridhar GR, Thota H, Allam AR, Suresh Babu C, Silva Prasad A, Divakar C. Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection? Lipids Health Dis 2006; 5: 28.
49. Baptista T, De Mendoza S, Beaulieu S, Bermudez A, Martinez M. The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management. Metabolic Syndrome Rel Dis 2004; 2: 290-307.
50. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596-601.
51. Guha P, Roy K, Sanyal D, Dasgupta T, Bhattacharya K. Olanzapine-induced obesity and diabetes in Indian patients: a prospective trial comparing olanzapine with typical antipsychotics. J Indian Med Assoc 2005; 103: 660-4.
52. Tighe S, Dinan T. An overview of the central control of weight regulation and the effect of antipsychotic medication. J Psychopharmacology 2005; 19 (Suppl): 36-46.
53. Best L, Yates AP, Reynolds GP. Actions of antipsychotic drugs on pancreatic beta cell function: contrasting effects of clozapine and haloperidol. J Psychopharmacology 2005; 19: 597-601.
54. Melkersson K. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro. Eur Neuropsychopharmacol 2004; 14: 115-9.
55. Melkersson KI, Dahl ML. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology (Berl) 2003; 170: 157-66.
56. Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, et al. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease. A placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 2005; 54: 862-71.
57. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686-96.
58. Davis JM. The choice of drugs for schizophrenia. N Engl J Med 2006; 354: 518-20.
59. Citrome LL, Jaffe AB. Relationship of atypical antipsychotics with development of diabetes mellitus. Ann Pharmacotherap 2003; 37: 1849-57.
60. Lambert TJR, Chapman LH, Consensus Working Group. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 2004; 181: 544-8.
61. Schwartz TL, Nihalani N, Virk S, Jindal S, Chilton M. Psychiatric medication-induced obesity: treatment options. Obesity Rev 2004; 5: 233-8.
62. Sridhar GR. Gender differences in childhood diabetes. Intl J Diab Dev Countries 1996; 16: 108-13.
63. Sridhar GR. Diabetes mellitus in children below the age of five. Indian J Endocrinol Metab 1997; 1: 13-5.
64. Ryan CM. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 1998; 11: 86-93.
65. Jyothi K, Susheela S, Kodali VR, Balakrishnan S, Seshaiah V. Poor cognitive task performance of insulin-dependent diabetic children (6-12 years) in India. Diabetes Res Clin Pract 1993; 20: 209-13.
66. Sridhar GR, Madhu K. Psycho-social aspects of diabetes. In: Ahuja MMS, Tripathy BB, Moses SGP, Chandalia HB, Das AK, Rao PV, et al, editors. RSSDI textbook of diabetes. Hyderabad: Research Society for the Study of Diabetes in India; 2002 p. 737-55.
67. Ryan C, Longstreet C, Morrow L. The effects of diabetes mellitus on the school attendence and school achievements of adolescents. Child Care Health Dev 1985; 11: 229-40.
68. Peveler RC, Bryden KS, Neil HA, Fairburn CG, Mayou RA, Dunger DB, et al. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes. Diabetes Care 2005; 28: 84-8.
69. Colton P, Olmsted M, Daneman D, Rydall A, Rodin G. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diabetes Care 2004; 27: 1654-9.
70. Maharaj SI, Rodin GM, Olmsted MP, Connolly JA, Daneman D. Eating disturbances in girls with diabetes: the contribution of adolescent self-concept, maternal weight and shape concerns and mother-daughter relationships. Psychol Med 2003; 33: 525-39.
71. Rodin G, Olmsted MP, Rydall AC, Maharaj SI, Colton PA, Jones JM, et al. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res 2002; 53: 943-9.
72. Affenito SG, Adams CH. Are eating disorders more prevalent in females with type 1 diabetes mellitus when impact of insulin omission is considered? Nutr Rev 2001; 59: 179-82.
73. Herpertz S, Albus C, Kielmann R, Hagemann-Patt H, Lichtblau K, Kohle K, et al. Comorbidity of diabetes mellitus and eating disorders: a follow-up study. J Psychosom Res 2001; 51: 673-8.
74. Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22: 1956-60.
75. Hoffman RP. Eating disorders in adolescents with type 1 diabetes. A closer look ata complicated condition. Postgrad Med 2001; 109: 67-9, 73-4.
76. Antisdel JE, Chrisler JC. Comparison of eating attitudes and behaviors among adolescent and young women with type 1 diabetes mellitus and phenylketonuria. J Dev Behav Pediatr 2000; 21: 81-6.
77. Nielsen S, Emborg C, Molbak AG. Mortality in concurrent type 1 diabetes and anorexia nervosa. Diabetes Care 2002; 25: 309-12.
78. Olmsted MP, Daneman D, Rydall AC, Lawson ML, Rodin G. The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord 2002; 32: 230-9.
79. Madhu K, Sridhar GR. Model for coping with diabetes. Intl J Diab Dev Countries 2001; 21: 103-11.
80. Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, Wickramaratne P, et al. Group Interpersonal Psychotherapy for Depression in Rural Uganda: A randomized controlled trial. JAMA 2003; 289: 3117-24.
81. Sridhar GR. Containing the diabetes epidemic. Natl Med J India 2003; 16: 57-60.